Literature DB >> 9830592

Central venous catheter-related bacteraemia in critically ill neonates: risk factors and impact of a prevention programme.

A Maas1, P Flament, A Pardou, A Deplano, M Dramaix, M J Struelens.   

Abstract

Risk factors for central venous catheter (CVC)-related bacteraemia among infants admitted to a neonatal intensive care unit (NICU) were analysed and the impact of surveillance and continuing education on the incidence of this complication investigated. Among patients admitted to a NICU, CVC-related bacteraemia increased from 1/15 (7%) in 1987 to 11/26 (42%) in 1988 (P = 0.01). Coagulase-negative staphylococci isolated from bacteraemia patients showed clonal diversity by plasmid and chromosomal fingerprinting. A review of CVC care procedures suggested breaches in aseptic techniques. Catheter-care technique was revised to ensure maximal aseptic precautions, including the use of sterile gloves, gown and drapes. The new policy was promoted by a continuing education programme and regular feed-back of CVC-related bacteraemia incidence to NICU staff. In the four-year follow-up period, the attack-rate of CVC-related bacteraemia decreased to 18/156 (12%) patients [relative risk (RR): 0.27, 95% confidence interval (CI); 0.15-0.51; P < 0.001 vs the previous period]. By using the Cox's model proportional hazards, very low birthweight and the period before use of strict aseptic CVC care were found to be predictors of increased risk of catheter-related bacteraemia after adjustment for duration of catheterization. These data provide further evidence that strict aseptic precautions during the maintenance and utilization of CVC can contribute to lower the risk of catheter infection in critically ill neonates. Regular feedback of surveillance data was associated with a progressive decrease in incidence of infection, suggesting that it improved staff compliance with aseptic precautions.

Entities:  

Mesh:

Year:  1998        PMID: 9830592     DOI: 10.1016/s0195-6701(98)90139-6

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  8 in total

1.  Central venous lines in neonates: a study of 2186 catheters.

Authors:  D W Cartwright
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-11       Impact factor: 5.747

Review 2.  New technologies to prevent intravascular catheter-related bloodstream infections.

Authors:  L A Mermel
Journal:  Emerg Infect Dis       Date:  2001 Mar-Apr       Impact factor: 6.883

3.  Is an increased dwell time of a peripherally inserted catheter associated with an increased risk of bloodstream infection in infants?

Authors:  P Brian Smith; Daniel K Benjamin; C Michael Cotten; Eric Schultz; Rose Guo; Lisa Nowell; Mary Laura Smithwick; Courtney D Thornburg
Journal:  Infect Control Hosp Epidemiol       Date:  2008-08       Impact factor: 3.254

4.  Central venous catheter sepsis in surgical newborns.

Authors:  Michael D Klein; Kim Rood; Pam Graham
Journal:  Pediatr Surg Int       Date:  2003-08-02       Impact factor: 1.827

5.  Antibiotic susceptibility of coagulase-negative staphylococci isolated from very low birth weight babies: comprehensive comparisons of bacteria at different stages of biofilm formation.

Authors:  Yue Qu; Andrew J Daley; Taghrid S Istivan; Suzanne M Garland; Margaret A Deighton
Journal:  Ann Clin Microbiol Antimicrob       Date:  2010-05-27       Impact factor: 3.944

6.  Prevention of neonatal late-onset sepsis: a randomised controlled trial.

Authors:  Gary Alcock; Helen G Liley; Lucy Cooke; Peter H Gray
Journal:  BMC Pediatr       Date:  2017-04-04       Impact factor: 2.125

7.  The effect of hospital infection control policy on the prevalence of surgical site infection in a tertiary hospital in South-South Nigeria.

Authors:  Seiyefa Fun-Akpa Brisibe; Best Ordinioha; Precious K Gbeneolol
Journal:  Niger Med J       Date:  2015 May-Jun

8.  Adult 'PICC' Device May be Used as a Tunnelled Central Venous Catheter in Children.

Authors:  Brooke T Lawson; Ian A Zealley
Journal:  Cardiovasc Intervent Radiol       Date:  2018-01-17       Impact factor: 2.740

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.